Clinical trial
OVI-DETECT Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
NCT04971421 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OVI-DETECT Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 14, 2021
- Completion date
- October 1, 2024
- Enrollment
- 450 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.